Dr. Lal Pathlabs Limited - Company Profile

It is a healthcare public limited company based in New Delhi, Delhi, India, established in 1995.
1995 New Delhi, Delhi, India Active
Last Updated:
Access Report
About Dr. Lal Pathlabs Limited

Dr. Lal Pathlabs Limited, a active public limited company, was established on 14 February 1995 in New Delhi, Delhi, India. Engaging in diagnostic centers & pathology labs within the hospital and medical care sector, it holds CIN: L74899DL1995PLC065388. Registered under ROC Roc Delhi. it is listed on BSE: 539524 and NSE: LALPATHLAB. It has an authorized capital of ₹200.00 Cr and a paid-up capital of ₹167.55 Cr.

Formerly known as Dr. Lal Pathlabs Private Limited. It upholds a compliant status. In 2024, it reported revenue of ₹2,026.86 Cr and a net worth of ₹1,899.66 Cr. Employing 4,081 professional, Its leadership includes Arun Duggal (Director), Rahul Sharma (Director), Gurinder Singh Kalra (Director). Past directors included Sandeep Singhal, Saurabh Srivastava, Dilip Bidani. It holds ₹225.06 Cr open charges and ₹343.80 Cr settled loans. Its latest AGM occurred on 28 June 2025, with the balance sheet filed on 31 March 2025. It is based at Block E, Sector-18 Rohini, New Delhi, Delhi, 110085.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    L74899DL1995PLC065388

  • Registration Number

    065388

  • Incorporation Date

    14 February 1995

  • Authorized Capital

    ₹200.00 Cr

  • Paid-Up Capital

    ₹167.55 Cr

  • ROC Code

    Roc Delhi

  • Listing Status

    Listed (BSE: 539524, NSE: LALPATHLAB)

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 200.00 Cr
  • Paid Up Capital ₹ 167.55 Cr
  • Company Age 30 Year, 11 Months
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 225.06 Cr
  • Satisfied Charges ₹ 343.80 Cr
  • Revenue Growth **** 11.63%
  • Profit Growth **** 31.47%
  • Ebitda **** 21.39%
  • Net Worth 12.42%
  • Total Assets **** 4.11%
Company report

Dr. Lal Pathlabs Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Dr. Lal Pathlabs Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Dr. Lal Pathlabs Limited?
Current Directors
Name Designation Appointment Date Status
Arun Duggal Director 02 Feb 2023 Current
Rahul Sharma Director 22 Jul 2005 Current
Gurinder Singh Kalra Director 27 Jul 2023 Current
Rajit Mehta Director 27 Jul 2023 Current
Archana Lal Erdmann Director 17 May 2019 Current
Arvind Lal Whole-Time Director 14 Feb 1995 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Nominee Director 07 Oct 2016 Past
Pramod Abcsdd Additional Director 29 Sep 2015 Past
Pramod Abcsdd Cfo(Kmp) 10 Aug 2018 Past
Pramod Abcsdd Additional Director 29 Sep 2015 Past
Pramod Abcsdd Director 28 Sep 2015 Past
Pramod Abcsdd Additional Director 29 Sep 2015 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Dr. Lal Pathlabs.

Dr. Lal Pathlabs Limited, for the financial year ended 2024, experienced significant growth in revenue, with a 11.63% increase. The company also saw a substantial improvement in profitability, with a 31.47% increase in profit. The company's net worth Soared by an impressive increase of 12.42%.

Dr. Lal Pathlabs revenue growth over time
Dr. Lal Pathlabs profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 11.63%
*******
*******
*******
*******
Revenue from Operations
*******
 11.18%
*******
*******
*******
*******
Total Assets
*******
 4.11%
*******
*******
*******
*******
Profit or Loss
*******
 31.47%
*******
*******
*******
*******
Net Worth
*******
 12.42%
*******
*******
*******
*******
EBITDA
*******
 21.39%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Dr. Lal Pathlabs?

In 2023, Dr. Lal Pathlabs had a promoter holding of 55.03% and a public holding of 44.97%. The company had 8 Subsidiaries. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹2,250,613,000.00

Satisfied Charges

₹3,437,971,891.00

Charges Breakdown by Lending Institutions
  • Axis Bank Limited : 185.00 Cr
  • Others : 40.00 Cr
  • State Bank Of Baroda : 0.06 Cr
Latest Charge Details
Date Lender Amount Status
10 Nov 2021 Others ₹40.00 Cr Open
09 Nov 2021 Axis Bank Limited ₹185.00 Cr Open
19 Apr 1988 State Bank Of Baroda ₹0.61 M Open
24 Jun 2022 Hdfc Bank Limited ₹250.00 Cr Satisfied
07 Dec 2020 Others ₹10.00 Cr Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Dr. Lal Pathlabs?

Dr. Lal Pathlabs has a workforce of 4081 employees as of Apr 01, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Dr. Lal Pathlabs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dr. Lal Pathlabs's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Dr. Lal Pathlabs
Recent Activity within the Organization
  • Annual General Meeting

    The activity Dr. Lal Pathlabs Limited last Annual general meeting of members was held on 28 Jun 2025 as per latest MCA records. was completed.

  • Balance Sheet

    The activity Dr. Lal Pathlabs Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi. was completed.

  • Charges

    Progress on A charge registered on 24 Jun 2022 via Charge ID 100594143 with Hdfc Bank Limited was fully satisfied on 10 Mar 2025. was documented.

  • Director Appointment

    Progress on Shankha Banerjee was appointed as a Ceo was appointed as a Ceo on 30 May 2024 & has been associated with this company since 1 year 8 months . was documented.

  • Director Appointment

    The activity Gurinder Singh Kalra was appointed as a Director was appointed as a Director on 27 Jul 2023 & has been associated with this company since 2 years 6 months . was completed.

  • Director Appointment

    The activity Rajit Mehta was appointed as a Director was appointed as a Director on 27 Jul 2023 & has been associated with this company since 2 years 6 months . was completed.

Explore recent activity and updates - View Recent Activity

Recent News, Updates & Announcement

Explore news and more updates - View Recent News

Frequently Asked Questions
What is the CIN of Dr. Lal Pathlabs Limited?

The CIN of Dr. Lal Pathlabs Limited is L74899DL1995PLC065388.

Where is Dr. Lal Pathlabs Limited headquartered?

Dr. Lal Pathlabs Limited is headquartered at Block E, Sector-18 Rohini, New Delhi, Delhi, 110085.

When was Dr. Lal Pathlabs Limited incorporated?

Dr. Lal Pathlabs Limited was incorporated on 14 February 1995.

Who are the current directors of Dr. Lal Pathlabs Limited?

The current directors of Dr. Lal Pathlabs Limited are

What is the primary industry of Dr. Lal Pathlabs Limited?

The primary industry of Dr. Lal Pathlabs Limited is Hospital And Medical Care.

Is Dr. Lal Pathlabs Limited a listed company?

Dr. Lal Pathlabs Limited is listed. It is listed on BSE: 539524 and NSE: LALPATHLAB.

What is the capital structure of Dr. Lal Pathlabs Limited?

The authorized capital of Dr. Lal Pathlabs Limited is ₹200.00 Cr, and the paid-up capital is ₹167.55 Cr.

What is the compliance status of Dr. Lal Pathlabs Limited?

The compliance status of Dr. Lal Pathlabs Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available